DIFFERENCES OF MAGNESIUM SERUM LEVELS BEFORE AND AFTER THE ADMISSION OF MgSO4 IN PREECLAMPSIA PATIENTS

SARMA N. LUMBANRAJA; MUHAMMAD RAFI J. ADNANI; SARAH DINA; MUARA P. LUBIS; HANUDSE HARTONO; DERI EDIANTO

doi:10.22159/ijcpr.2020v12i3.38331

Authors

SARMA N. LUMBANRAJA Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan
MUHAMMAD RAFI J. ADNANI Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan
SARAH DINA Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan
MUARA P. LUBIS Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan
HANUDSE HARTONO Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan
DERI EDIANTO Department of Obstetrics and Gynecology, Medical Faculty, Universitas Sumatera Utara, H. Adam Malik General Hospital Medan

DOI:

https://doi.org/10.22159/ijcpr.2020v12i3.38331

Keywords:

Preeclampsia, Eclampsia, Magnesium sulfate

Abstract

Objective: The definitive treatment of preeclampsia until the fetus and placenta are delivered with magnesium sulfate (MgSO4) is a modality for the prevention and treatment of eclampsia. This study aims to determine the differences in serum magnesium (Mg) levels between before and after administration of MgSO4 in preeclampsia patients.

Methods: This research was an analytical study with experimental design with one group pre and post-test control group design in 4 hospitals in Medan City, North Sumatera, Indonesia from July to November 2019, the preeclampsia group and as a control group is the normal pregnant women. Statistical analysis was performed to determine differences in initial serum Mg levels in the two groups, and differences in serum Mg levels before and after administration of MgSO4 in the preeclampsia group.

Results: The study was conducted on 50 samples, divided into 2 groups with a total of 25 samples each. The mean Mg of serum in the preeclampsia group was 1,39 mEq/l (SD±0,28) lower than the control group, which was 1,53 mEq/l (SD±0,17) (p = 0.004). The average Mg level in preeclampsia patients before administration of MgSO4 was 1,39 mEq/l (SD±0,28), after MgSO4 administration, the average Mg level became 4,90 mEq/l (SD±0,37) (p<0,001).

Conclusion: MgSO4 administration provides a significant increase in serum Mg levels in preeclampsia women. Serum Mg levels in preeclampsia patients are significantly lower than in women with normal pregnancies.

Downloads

Download data is not yet available.

References

1. World Health Organization. Trends in maternal mortality 1990 to 2015; 2015.
2. Menteri Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun. Kementerian Kesehatan Republik Indonesia; 2017. p. 105-6.
3. Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a who systematic analysis. Lancet Glob Health 2014;2:e323–e333.
4. Peres GM, Mariana M, Cairrao E. Pre-eclampsia and eclampsia: an update on the pharmacological treatment applied in portugal. J Cardiovasc Dev Dis 2018;5:3.
5. Roy HL, Nargis S, Mahmud SH. Evaluation of serum magnesium level in preeclampsia. Bangladesh J Med Biochem 2017;10:10-5.
6. Koofreh ME, Mabel ED, Dorcas OE. The prevalence of preec-lampsia among pregnant women in the university of calabar teach¬ing hospital calabar. Saudi J Health Sci 2015;3:133-6.
7. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesth Belg 2014;65:137-49.
8. Das R, Biswas S. Eclampsia: the major cause of maternal mortality in Eastern India. Ethiopia Journal of Health Science; 2015.
9. Kanagal DV, Rajesh A, Rao K, Devi UH, Shetty H, Kumari S. Levels of serum calcium and magnesium in preeclamptic and normal pregnancy: a study from coastal India. J Clin Diag Res 2014;8:1-4.
10. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia. Clinical Pharmacokinetiks; 2000.
11. Lambe S, Mahajan B, Muddeshwar M. Comparative study of serum calcium, magnesium and zinc levels in preeclampsia and normal pregnancy. Int J Recent Trends Sci Technol 2014;9:422-6.
12. Saila BS, Kala C, Saradamba K. Serum calcium and magnesium levels in women presenting with pre-eclampsia: a case-control study in North Coastal Andhra Pradesh. IOSR J Dent Med Sci 2014;14:44-6.
13. Vafaei H, Dalili M, Hashemi SA. Serum concentration of calcium, magnesium and zinc in normotensive versus preeclampsia pregnant women: a descriptive study in women of Kerman province of Iran. Iran J Reprod Med 2015;13:23-6.
14. Nahar K, Yasmin H, Shamsuddin L. Serum magnesium in preeclampsia and eclampsia. Bangladesh J Obstet Gynaecol 2010;25:15-9.
15. Singh A, Verma AJ, Hassan G. Serum magnesium levels in patients with pre-eclampsia and eclampsia with different regimens of magnesium sulphate. GJMEDPH 2013;2:1-9.
16. Lumbanraja SN. Proteinuria is not a prequisite criteria for preeclampsia diagnosis. Res J Med Sci 2018;10:755-8.
17. Abdellah A, Abdrabo AA. Assessment of serum calcium, magnesium, copper, and zinc leve; s in sudanese pregnant women with preeclampsia. Global Adv Res J Med Med Sci 2014;3:33-6.
18. Grober U, Joachim S, dan Klaus K. Magnesium in prevention and therapy. Nutrients 2015;7:8199-226.
19. Purohit A, Vyas RK, Manju LS, Yogita S, Anita V. Serum magnesium status in preeclampsia. Int J Med Sci Edu 2016;3:9-15.
20. Galmohammad S, Amirabi A, Yazdian M. Evaluation of serum calcium, magnesium, copper, and zinc levels in woman with pre-eclampsia. Iran J Med Sci 2008;33:231-4.
21. Lumbanraja SN. Determining the maternal characteristics that predicts the adverse outcomes for patients with preeclampsia. J Health Translational Med 2013;16:5-10.
22. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009;40:1169-75.
23. Pascoal AC, Katz L, Pinto MH, Santos CA, Braga LC, Maia SB, et al. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: a randomized clinical trial. Medicine 2019;98:e16779.
24. Easterling T, Hebert M, Bracken H, Darwish E, Ramadan MC, Shaarawy S, et al. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion. BMC Pregnancy Childbirth 2018;18:290.
25. Imaralu JO, Olaleye AO, Badejoko OO, Loto OM, Ogunniyi SO. The use of magnesium sulphate (MgSO4) for seizure prophylaxis: clinical correlates in a Nigerian tertiary hospital. Int J Med Biomed Res 2015;4:72-81.
26. Smith JM, Lowe RF, Fullerton J. An integrative review of the side effects related to the use of magnesium sulfate for preeclampsia and eclampsia management. BMC Pregnancy Childbirth 2013;13:34.